The prevalence and predictors of pre-diabetes and diabetes among adults 40-70 years in Kharameh cohort study: A population-based study in Fars province, south of Iran.
Associated factors
Health surveys
Impaired glucose tolerance
Logistic regression
Mellitus
type2
Journal
Journal of diabetes and metabolic disorders
ISSN: 2251-6581
Titre abrégé: J Diabetes Metab Disord
Pays: Switzerland
ID NLM: 101590741
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
31
08
2021
accepted:
16
11
2021
entrez:
8
6
2022
pubmed:
9
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
In this study, the prevalence of diabetes and pre-diabetes (pre-DM) has been estimated; also, some factors related to diabetes and pre-diabetes in the city of Kharameh, southern Iran, were investigated. This cross-sectional study was conducted on a total of 10,474 subjects aged 40-70 years who participated in phase one of PERSIAN Kharameh cohort carried out between 2015 and 2016. Eligible individuals were included in the study by census method. Prevalence of diabetes is 20.17% (95% CI: 19.95-20.39) and that of pre-diabetes is 15.74% (95% CI 15.54-15.93). Multivariate logistic regression results showed that the prevalence of diabetes had a direct relationship with increasing age (p < 0.001), being single (p = 0.005), family history of diabetes (p < 0.001), abdominal obesity (p < 0.001), hypertension (p: < 0.001), and high triglycerides (p: < 0.001); also, it had an inverse relationship with residence in rural areas (p < 0.001), education (p < 0.001), and employment (p < 0.001).Also, the prevalence of pre-diabetes showed a direct relationship with increasing age (60-70 years p = 0.010), being single (p = 0.004), living in rural areas (P < 0.001), having a family history of diabetes ( both P = 0.023), abdominal obesity (P < 0.001), hypertension (P < 0.001), high cholesterol (P < 0.001) and high triglycerides (P < 0.001), and an inverse relationship with female gender (P < 0.001), education (high school P = 0.022), employment (P = 0.010), and smoking habit (P = 0.019). These results were all statistically significant. The present study shows the high prevalence of diabetes and pre- diabetes in the city of Kharameh. Diabetes prevention policies should be developed and implemented for the public.
Identifiants
pubmed: 35673470
doi: 10.1007/s40200-021-00938-5
pii: 938
pmc: PMC9167410
doi:
Types de publication
Journal Article
Langues
eng
Pagination
85-95Informations de copyright
© Springer Nature Switzerland AG 2021.
Déclaration de conflit d'intérêts
Conflict of interestThe authors declare that they have no conflict of interest to the publication of this article.
Références
BMC Public Health. 2012 Sep 24;12:821
pubmed: 22998969
Diabetes Metab J. 2018 Oct;42(5):415-424
pubmed: 30113146
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S347-S350
pubmed: 28314537
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Diabetes Metab J. 2017 Dec;41(6):449-456
pubmed: 29272083
Diabetes Res Clin Pract. 2020 Feb;160:107931
pubmed: 31794806
Diabet Med. 2012 Feb;29(2):190-7
pubmed: 21883431
Int J Endocrinol. 2018 Apr 26;2018:9317987
pubmed: 29853887
East Mediterr Health J. 2015 Sep 08;21(6):412-9
pubmed: 26370000
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
Appl Physiol Nutr Metab. 2019 Oct;44(10):1099-1104
pubmed: 31386561
Sci Rep. 2017 Sep 5;7(1):10472
pubmed: 28874777
PLoS One. 2015 Jul 22;10(7):e0132505
pubmed: 26200913
BMJ. 2016 Nov 23;355:i5953
pubmed: 27881363
BMJ Open. 2018 Mar 30;8(3):e020406
pubmed: 29602856
J Diabetes Res. 2019 Sep 03;2019:5869206
pubmed: 31565657
Int J Environ Res Public Health. 2016 Aug 10;13(8):
pubmed: 27517947
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Clin Diabetes Endocrinol. 2019 May 9;5:5
pubmed: 31086677
Am J Epidemiol. 2018 Apr 1;187(4):647-655
pubmed: 29145581
Diabetes Metab Syndr. 2016 Apr-Jun;10(2 Suppl 1):S114-8
pubmed: 27312373
BMC Geriatr. 2020 Apr 15;20(1):138
pubmed: 32293307
Lancet. 2018 Sep 22;392(10152):1072-1088
pubmed: 30264707
Int J Med Sci. 2014 Sep 06;11(11):1185-200
pubmed: 25249787
Acta Diabetol. 2018 Mar;55(3):233-242
pubmed: 29274011
J ASEAN Fed Endocr Soc. 2019;34(1):80-86
pubmed: 33442140
Arch Iran Med. 2019 Nov 01;22(11):633-639
pubmed: 31823628
BMC Public Health. 2020 Feb 3;20(1):166
pubmed: 32013917
Prev Med. 2016 Sep;90:177-83
pubmed: 27353304
Clin Diabetes. 2018 Jan;36(1):14-37
pubmed: 29382975
Epidemiol Health. 2019;41:e2019029
pubmed: 31319658
N Engl J Med. 2013 Oct 3;369(14):1336-43
pubmed: 24088093
Yonsei Med J. 2018 Jan;59(1):92-100
pubmed: 29214782
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
J Glob Health. 2017 Jun;7(1):011103
pubmed: 28702177
Diabetes Ther. 2020 Feb;11(2):479-494
pubmed: 31916213
Endocrinol Metab Clin North Am. 2016 Dec;45(4):751-764
pubmed: 27823603
Diabetes Res Clin Pract. 2018 Oct;144:213-223
pubmed: 30179683
Diabetes Metab Syndr Obes. 2019 Dec 31;12:2799-2809
pubmed: 32021343
Turk J Med Sci. 2015;45(6):1220-7
pubmed: 26775374
BMC Endocr Disord. 2012 Aug 16;12:15
pubmed: 22898260
Sleep Health. 2015 Mar;1(1):40-43
pubmed: 29073412
Arch Public Health. 2019 Aug 06;77:36
pubmed: 31402976
Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47
pubmed: 24842598
Arch Iran Med. 2014 Jan;17(1):54-61
pubmed: 24444064
Diabetes Res Clin Pract. 2018 Jun;140:271-278
pubmed: 29626582
J Pak Med Assoc. 2016 Aug;66(8):922-7
pubmed: 27524520
Sci Rep. 2017 Oct 18;7(1):13461
pubmed: 29044139